googlefd16b42746daa692.html

OUR PEOPLE

Prof Monica Slavin

 

Centre and Innovations lead

Immunocompromised Host Infection Service, Victorian Comprehensive Cancer Centre, Department of Infectious Diseases, Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Monica is highly productive in clinical research and knowledge translation and views improving safety and quality of services to be an integral part of her role. 

FULL BIO 

Prof Karin Thursky

Implementation lead

Department of Infectious Diseases, Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Karin is a national leader in Antimicrobial Stewardship (AMS) with over 15 years experience in health services research and implementation science. She is internationally recognised as an expert in the area of AMS, particularly in relation to computerised systems. 

FULL BIO

A Prof Leon Worth

Surveillance lead

Department of Infectious Diseases, Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Leon works to inform and evaluate surveillance for healthcare-associated infections across all Victorian hospitals, ensuring that state government health priorities are supported and education is provided to all hospital staff responsible for surveillance.

FULL BIO

Dr Megan Crane

Centre Manager

Department of Infectious Diseases, Peter MacCallum Cancer Centre

Megan has a PhD in Immunology from Monash University and has completed two postdocs in HIV-HBV co-infection at the Doherty Institute of Infection and Immunity. She has a strong interest in infections in the immunocompromised host. She comes on board the NCIC as Research Manager.

Dr Ben Teh

Clinician and Postdoc: Innovations

Department of Infectious Diseases, Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Ben  is a clinician researcher with primary clinical and research interests in the area of infections in cancer patients. He is interested in developing novel approaches utilising functional and numerical immune profiling to predict risk of infection in patients with cancer and advancing measures to prevent infection in this vulnerable patient group. 

maria dikeakos.jpg

Ms Maria Dikeakos

Program manager: Implementation

Department of Infectious Diseases, Peter MacCallum Cancer Centre

Maria is a Microbiologist who has previously worked in various clinical laboratories around Melbourne.  She has also been heavily involved in cancer coordination, pathway mapping, strategic planning and program management at the Royal Melbourne and Royals Children’s Hospitals.  She is currently the Febrile Neutropenia Program Manager at the Peter MacCallum Cancer Centre.

Dr Jason Trubiano

Clinician: Innovations

Department of Infectious Diseases, Peter MacCallum Cancer Centre and Austin Health

Jason is an infectious diseases and antimicrobial stewardship physician with the primary research interest of antibiotic allergy and its impact on prescribing in the immunocompromised host. He is interested in the development of clinical programs that aid antibiotic allergy 'de-labeling' to improve antibiotic prescribing and concurrently develop novel ex vivo T-cell diagnostics that aid drug causality assessments in cancer patients with antibiotic associated severe cutaneous adverse drug reactions.

Prof Mei Krisnasamy

Chief Investigator: Implementation

Chair, Cancer Nursing University of Melbourne and Nursing Research and Education Lead, Victorian Comprehensive Cancer Centre. 

 

Prof Andrew Grigg

Chief Investigator: Implementation

Director, Clinical Haematology, Olivia Newton-John Cancer & Wellness Centre, Austin Health

Prof Grigg is a haematologist/transplant physician with a long history of interest in infections in immunocompromised patients, and has a number of publications covering areas such as HVZ and CMV reactivation, bacterial infective complications of central lines and  fungal prophylaxis. His current research interest is in evidence-based prophylaxis in this patient population.

Prof Marc Pellegrini

Chief Investigator: Surveillance

WEHI

Marc Pellegrini is an infectious diseases physician and Head of the Infection and Immunity Division at the Walter and Eliza Hall Institute. His research is focused on understanding how pathogens interact with host cells to cause disease and conversely how hosts adapt to fight infections.These insights are used to help predict susceptibility to infections and mitigate disease by boosting and or assisting the immune system to fight pathogens. 

 

Dr Lisa Hall

Chief Investigator: Surveillance

Institute of Health and Biomedical Innovation, Queensland University of Technology

Lisa’s research focuses on the interface between evidence, policy and implementation, to improve the impact of programs that reduce healthcare-associated infections.  

FULL BIO

Dr Tim Spelman

Chief Investigator: Statistics

Burnet Institute & Doherty Institute of Infection and Immunity

Tim is Head of Statistics at the MSBase Registry, Assistant Professor at the Department of Clinical Neuroscience at the Karolinska Institute and senior statistician at the Doherty and Burnet Institutes.

Dr Abby Douglas

Clinician and PhD student: Innovations

Department of Infectious Diseases, Peter MacCallum Cancer Centre

Abby is a consultant infectious diseases physician and PhD student. Her interest is in infections in the immunocompromised host, with particular interests in invasive fungal infections and novel diagnostics to assess net immune status and to determine the aetiology of febrile neutropenia. 

googlefd16b42746daa692.html